Assessment of Perinatal Outcome by uSe of Tocolysis in Early Labour (APOSTEL IV); Nifedipine versus placebo in the treatment of preterm premature rupture of membranes - APOSTEL IV

Academic Medical Centre0 个研究点目标入组 120 人开始时间: 2012年2月7日最近更新: 2015年2月16日

适应症

试验速览

暂无简介。

•All women with a gestational age between 24+0/7 and 33+6/7 weeks with ruptured membranes without other signs of active labour are eligible for the trial.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 120
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Women with = 3 contractions per 10 minutes, woman with symptoms justifying start of tocolysis, women with ruptured membranes longer than 72 hour, women having signs of chorioamnionitis or signs of intra uterine infection, women whose child has signs of fetal distress (abnormal CTG, abnormal biophysical profile) or women with any contraindication for the use of nifedipine or having a maternal disease (hypertension, HELLP syndrome, preeclampsia or other) as reason for delivery.

发起方

Academic Medical Centre